Scienture Holdings (SCNX) Non-Current Assets (2013 - 2026)
Scienture Holdings' (SCNX) quarterly Non-Current Assets came in at $78.5 million in Q2 2026, down 5.75% year-over-year from $83.3 million in Q2 2025, and up 3.48% quarter-over-quarter from $75.9 million in Q1 2026.
Analysis
Scienture Holdings (SCNX) Non-Current Assets (2013 - 2026) Analysis & Trends
Scienture Holdings has disclosed Non-Current Assets across 14 years of filings, most recently posting $78.5 million for Q2 2026.
- In Q2 2026, Non-Current Assets fell 5.75% year-over-year to $78.5 million; the TTM figure through Jun 2026 stood at $314.0 million (up 20.34% YoY), while the FY2025 annual figure was $76.3 million, down 22.61% from the prior year.
- Non-Current Assets came in at $78.5 million for Q2 2026 at Scienture Holdings, up from $75.9 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $98.5 million in Q4 2024 to a low of $1.6 million in Q4 2022.
- Average Non-Current Assets over 5 years is $41.3 million, with a median of $16.1 million recorded in 2023.
- Year-over-year, Non-Current Assets slipped 24.41% in 2024 and soared 2981.32% in 2025.
- Over 5 years, Non-Current Assets stood at $1.6 million in 2022, then surged by 504.85% to $9.8 million in 2023, then jumped by 907.67% to $98.5 million in 2024, then dropped by 22.61% to $76.3 million in 2025, then advanced by 2.98% to $78.5 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $78.5 million in Q2 2026, $75.9 million in Q1 2026, and $76.3 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 26.10 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 24.99 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 2.92 Bn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 1.83 Bn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 18.27 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 668.68 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 1.04 Bn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 1.11 Bn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 3.25 Mn |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | 78.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78.53 Mn |
| Mar 31, 2026 | 75.89 Mn |
| Dec 31, 2025 | 76.26 Mn |
| Jun 30, 2025 | 83.32 Mn |
| Mar 31, 2025 | 76.35 Mn |
| Dec 31, 2024 | 98.55 Mn |
| Jun 30, 2024 | 2.70 Mn |
| Mar 31, 2024 | 90.83 Mn |
| Dec 31, 2023 | 9.78 Mn |
| Sep 30, 2023 | 16.11 Mn |
| Jun 30, 2023 | 3.58 Mn |
| Dec 31, 2022 | 1.62 Mn |
| Sep 30, 2022 | 2.11 Mn |
| Jun 30, 2022 | 2.33 Mn |
| Mar 31, 2022 | 2.24 Mn |
| Dec 31, 2021 | 1.39 Mn |
| Sep 30, 2021 | 324,827.00 |
| Jun 30, 2021 | 359,863.00 |
| Mar 31, 2021 | 537,976.00 |
| Dec 31, 2020 | 571,404.00 |